In vivo expansion and activation of γδ T cells as immunotherapy for refractory neuroblastoma: A phase 1 study

INTRODUCTION: CD3+ γδ+ T cells comprise 2% to 5% of circulating T cells with Vγ9Vδ2+ cells the dominant circulating subtype. Vγ9Vδ2+ cells recognize non-peptide phosphoantigens and stress-associated NKG2D ligands expressed on malignant cells. Strategies that incorporate the tumoricidal properties of...

Descripción completa

Detalles Bibliográficos
Autores principales: Pressey, Joseph G., Adams, Julia, Harkins, Lualhati, Kelly, David, You, Zhiying, Lamb, Lawrence S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2016
Materias:
5700
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5265919/
https://www.ncbi.nlm.nih.gov/pubmed/27684826
http://dx.doi.org/10.1097/MD.0000000000004909

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5265919/
https://www.ncbi.nlm.nih.gov/pubmed/27684826
http://dx.doi.org/10.1097/MD.0000000000004909

Ejemplares similares